A detailed history of Two Sigma Securities, LLC transactions in Repligen Corp stock. As of the latest transaction made, Two Sigma Securities, LLC holds 10,644 shares of RGEN stock, worth $1.56 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,644
Previous 2,938 262.29%
Holding current value
$1.56 Million
Previous $370,000 328.11%
% of portfolio
0.03%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $923,101 - $1.29 Million
7,706 Added 262.29%
10,644 $1.58 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $53,640 - $81,778
447 Added 17.94%
2,938 $370,000
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $425,412 - $519,174
2,491 New
2,491 $458,000
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $386,363 - $491,403
2,784 New
2,784 $442,000
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $451,981 - $580,433
2,930 New
2,930 $493,000
Q2 2022

Aug 15, 2022

BUY
$140.68 - $188.02 $25,885 - $34,595
184 Added 14.22%
1,478 $240,000
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $86,236 - $138,008
535 Added 70.49%
1,294 $243,000
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $187,920 - $231,092
759 New
759 $201,000
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $285,338 - $474,967
-1,465 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $242,999 - $323,691
1,465 New
1,465 $292,000
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $196,168 - $249,127
-3,967 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $191,447 - $273,246
3,967 New
3,967 $209,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.